Clinical Trial Update: Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia [Phase 1, Phase 2]

View source ↗

Summary

This update announces the completion of a Phase 1/2 trial evaluating mesenchymal stem cells for relapsed/refractory severe acquired aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Sao Paulo | Conditions: Aplastic Anemia | Phase 1, Phase 2 | Status: COMPLETED